Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy.

Jenson HB, Gauntt CJ, Easley KA, Pitt J, Lipshultz SE, McIntosh K, Shearer WT; Pediatric Pulmonary and Cardiovascular Complication of HIV-1 Infection Study Group.

J Infect Dis. 2002 Jun 15;185(12):1798-802. Epub 2002 May 31.

2.

Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.

Tracy S, Höfling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ.

J Med Virol. 2000 Sep;62(1):70-81.

PMID:
10935991
3.

Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets.

Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA.

Diabetes. 2000 May;49(5):708-11.

PMID:
10905477
4.

Progress toward vaccines against viruses that cause heart disease.

Höfling K, Kim KS, Leser JS, Chapman NM, Willian S, Gauntt CJ, Tracy S.

Herz. 2000 May;25(3):286-90. Review.

PMID:
10904854
5.

Aloe polymannose enhances anti-coxsackievirus antibody titres in mice.

Gauntt CJ, Wood HJ, McDaniel HR, McAnalley BH.

Phytother Res. 2000 Jun;14(4):261-6.

PMID:
10861969
6.

The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.

Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP.

Virology. 2000 May 25;271(1):99-108.

7.

Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity.

Huber SA, Gauntt CJ, Sakkinen P.

Adv Virus Res. 1998;51:35-80. Review. No abstract available.

PMID:
9891585
8.

Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.

Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP.

Virology. 1998 May 10;244(2):302-14.

9.

Roles of the humoral response in coxsackievirus B-induced disease.

Gauntt CJ.

Curr Top Microbiol Immunol. 1997;223:259-82. Review. No abstract available.

PMID:
9294933
10.

Coxsackievirus B3 clinical isolates and murine myocarditis.

Gauntt CJ, Pallansch MA.

Virus Res. 1996 Mar;41(1):89-99. Erratum in: Virus Res 1996 Nov;45(1):69.

PMID:
8725105
11.

Coxsackievirus-induced chronic myocarditis in murine models.

Gauntt CJ, Tracy SM, Chapman N, Wood HJ, Kolbeck PC, Karaganis AG, Winfrey CL, Cunningham MW.

Eur Heart J. 1995 Dec;16 Suppl O:56-8.

PMID:
8682103
12.

Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.

Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R.

J Immunol. 1995 Mar 15;154(6):2983-95.

PMID:
7533190
14.

Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis.

McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, Kandolf R.

Clin Immunol Immunopathol. 1993 Aug;68(2):159-69. No abstract available.

PMID:
7689428
15.

Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis.

Gauntt CJ, Higdon AL, Arizpe HM, Tamayo MR, Crawley R, Henkel RD, Pereira ME, Tracy SM, Cunningham MW.

Clin Immunol Immunopathol. 1993 Aug;68(2):129-34. No abstract available.

PMID:
7689425
16.

Alpha-helical coiled-coil molecules: a role in autoimmunity against the heart.

Cunningham MW, Antone SM, Gulizia JM, McManus BA, Gauntt CJ.

Clin Immunol Immunopathol. 1993 Aug;68(2):118-23. No abstract available.

PMID:
7689424
17.

An encephalomyocarditis virus epizootic in a baboon colony.

Hubbard GB, Soike KF, Butler TM, Carey KD, Davis H, Butcher WI, Gauntt CJ.

Lab Anim Sci. 1992 Jun;42(3):233-9.

PMID:
1320151
18.

Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.

Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ.

Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1320-4.

19.

Detection of enteroviruses in cell cultures by using in situ transcription.

Carstens JM, Tracy S, Chapman NM, Gauntt CJ.

J Clin Microbiol. 1992 Jan;30(1):25-35.

20.

Autoimmune determinants of rheumatic carditis: localization of epitopes in human cardiac myosin.

Dell A, Antone SM, Gauntt CJ, Crossley CA, Clark WA, Cunningham MW.

Eur Heart J. 1991 Aug;12 Suppl D:158-62.

PMID:
1717271
21.

Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential.

Gauntt CJ, Arizpe HM, Higdon AL, Rozek MM, Crawley R, Cunningham MW.

Eur Heart J. 1991 Aug;12 Suppl D:124-9.

PMID:
1717270
22.
23.

Echovirus 22 is an atypical enterovirus.

Coller BA, Chapman NM, Beck MA, Pallansch MA, Gauntt CJ, Tracy SM.

J Virol. 1990 Jun;64(6):2692-701.

24.

Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization.

Chapman NM, Tracy S, Gauntt CJ, Fortmueller U.

J Clin Microbiol. 1990 May;28(5):843-50.

25.

Role of natural killer cells in experimental murine myocarditis.

Gauntt CJ, Godeny EK, Lutton CW, Fernandes G.

Springer Semin Immunopathol. 1989;11(1):51-9. Review. No abstract available.

PMID:
2546262
26.

Host factors regulating viral clearance.

Gauntt CJ, Godeny EK, Lutton CW.

Pathol Immunopathol Res. 1988;7(4):251-65. Review. No abstract available.

PMID:
2853344
27.

Immunopathologic basis of myocardial injury.

McManus BM, Gauntt CJ, Cassling RS.

Cardiovasc Clin. 1988;18(2):163-84. Review. No abstract available.

PMID:
2820575
29.

Murine natural killer cells limit coxsackievirus B3 replication.

Godeny EK, Gauntt CJ.

J Immunol. 1987 Aug 1;139(3):913-8.

PMID:
3036947
30.

Coxsackievirus group B replication in cultured fetal baboon aortic smooth muscle cells.

Godeny EK, Sprague EA, Schwartz CJ, Gauntt CJ.

J Med Virol. 1986 Oct;20(2):135-49.

PMID:
3021897
31.
32.

Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.

Godeny EK, Gauntt CJ.

J Immunol. 1986 Sep 1;137(5):1695-702.

PMID:
3018079
33.

Effects of viral infection on contraction of the diaphragm in mice.

McCarter R, McGee J, Witherspoon S, Gauntt CJ, Vardiman A.

Proc Soc Exp Biol Med. 1986 Jul;182(3):308-14.

PMID:
3012575
34.

Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3.

Lutton CW, Gudvangen RJ, Nealon TJ, Paque RE, Gauntt CJ.

J Med Virol. 1985 Dec;17(4):345-57.

PMID:
3001222
35.
36.

Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model.

Gauntt CJ, Arizpe HM, Kung JT, Ogilvie KK, Cheriyan UO.

Antimicrob Agents Chemother. 1985 Feb;27(2):184-91.

37.

Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice.

Lutton CW, Gauntt CJ.

J Interferon Res. 1985 Winter;5(1):137-46.

PMID:
2985716
38.

Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.

Gauntt CJ, Gomez PT, Duffey PS, Grant JA, Trent DW, Witherspoon SM, Paque RE.

J Virol. 1984 Nov;52(2):598-605.

39.

High-efficiency polyethylene glycol-mediated transformation of mammalian cells.

Klebe RJ, Harriss JV, Hanson DP, Gauntt CJ.

Somat Cell Mol Genet. 1984 Sep;10(5):495-502.

PMID:
6089359
40.

Murine forebrain anomalies induced by coxsackievirus B3 variants.

Gauntt CJ, Jones DC, Huntington HW, Arizpe HM, Gudvangen RJ, DeShambo RM.

J Med Virol. 1984;14(4):341-55.

PMID:
6096503
41.

Levamisole exacerbates coxsackievirus B3-induced murine myocarditis.

Gudvangen RJ, Duffey PS, Paque RE, Gauntt CJ.

Infect Immun. 1983 Sep;41(3):1157-65.

42.

Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants.

Gauntt CJ, Trousdale MD, Lee JC, Paque RE.

J Virol. 1983 Mar;45(3):1037-47.

43.

Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Gauntt CJ, Paque RE, Trousdale MD, Gudvangen RJ, Barr DT, Lipotich GJ, Nealon TJ, Duffey PS.

Infect Immun. 1983 Feb;39(2):851-64.

44.
45.
46.
47.

Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.

Trousdale MD, Paque RE, Nealon T, Gauntt CJ.

Infect Immun. 1979 Feb;23(2):486-95.

48.

Rhinovirus type 14 persistence in HeLa cells studied by use of guanidine.

Gauntt CJ.

J Med Virol. 1979;4(2):115-24. No abstract available.

PMID:
226654
49.

Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.

Gauntt CJ, Trousdale MD, LaBadie DR, Paque RE, Nealon T.

J Med Virol. 1979;3(3):207-20.

PMID:
225441
50.

Cytoplasmic DNA synthesis in rhinovirus type 14-inoculated KB cells.

Griffith MM, Kelley L, Upson R, Carlson E, Dinowitz M, Gauntt CJ.

Biochim Biophys Acta. 1978 Jul 24;519(2):331-47.

PMID:
208615

Supplemental Content

Loading ...
Support Center